Evidence map›Paper›PMID 39924100›Full record

ArticleBrain stimulation

Basal forebrain activation improves working memory in senescent monkeys.

Kendyl R Pennington, Luca Debs, Sophia Chung, Janki Bava, Clément M Garin, Fernando L Vale, Sarah K Bick, Dario J Englot, Alvin V Terry, Christos Constantinidis and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Brain stimulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07218081 (Cognitive Brain Aging Reversal From Deep Brain Stimulation for Alzheimer's Dementia), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07218081 phase1recruitingnot on this map

Cognitive Brain Aging Reversal From Deep Brain Stimulation for Alzheimer's Dementia: a Clinical Trial.

TypeinterventionalSponsorAugusta UniversityRan2026 to 2028Enrolled12ConditionsAlzheimer Dementia (AD)ArmsIntermittent deep brain stimulation of the nucleus basalis of Meynert
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kendyl R PenningtonDept Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Luca DebsDept Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Sophia ChungNeuroscience Program, Vanderbilt University, Nashville, TN, 37235, USA.
Janki BavaDept Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Clément M GarinDept Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Fernando L ValeDept Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Sarah K BickDept Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA; Dept Neurosurgery, Vanderbilt University, Nashville, TN, USA.
Dario J EnglotDept Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA; Dept Neurosurgery, Vanderbilt University, Nashville, TN, USA.
Alvin V TerryDept Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Christos ConstantinidisNeuroscience Program, Vanderbilt University, Nashville, TN, 37235, USA; Dept Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA; Dept Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Electronic address: christos.constantinidis.1@vanderbilt.edu.
David T BlakeDept Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA; Dept Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA. Electronic address: dblake@augusta.edu.

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Primate model of deep brain stimulation for Alzheimers and age-related cognitivedeclineRF1AG060754 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BLAKE, DAVID T, CONSTANTINIDIS, CHRISTOS · 2019 to 2019
$3.9M
Cholinergic influence on visual cognitive processingR01EY036089 · NEI · VANDERBILT UNIVERSITY · PI David T Blake, CHRISTOS CONSTANTINIDIS · 2025 to 2026
$1.3M
NEI NIH HHS R01 EY036089NIA NIH HHS RF1 AG060754NICHD NIH HHS P50 HD103537
6 · The paper itself

Abstract

Brain aging contributes to cognitive decline and risk of dementia. Degeneration of the basal forebrain cholinergic system parallels these changes in aging, Alzheimer's dementia, Parkinson's dementia, and Lewy body dementia, and thus is a common element linked to executive function across the lifespan and in disease states. Here, we tested the potential of one-hour daily intermittent basal forebrain stimulation to improve cognition in senescent Rhesus monkeys, and its mechanisms of action. Stimulation in five animals improved working memory duration in each animal over 8-12 weeks, with peak improvements observed in the first four weeks. In an ensuing three month period without stimulation, improvements were retained. With additional stimulation, performance remained above baseline throughout the 15 months of the study. Studies with a cholinesterase inhibitor in five animals produced inconsistent improvements in behavior. One of five animals improved significantly. Manipulating the stimulation pattern demonstrated selectivity for both stimulation and recovery period duration in two animals. Brain stimulation led to acute increases in cerebrospinal fluid levels of tissue plasminogen activator, which is an activating element for two brain neurotrophins, Nerve Growth Factor (NGF) and Brain-Derived Growth Factor (BDNF), in four animals. Stimulation also led to improved glucose utilization in stimulated hemispheres relative to contralateral in three animals. Glucose utilization also consistently declines with aging and some dementias. Together, these findings suggest that intermittent stimulation of the nucleus basalis of Meynert improves executive function and reverses some aspects of brain aging.

Indexed as

AgingBasal ForebrainMemory, Short-TermAnimalsMacaca mulattaMaleTissue Plasminogen ActivatorTissue Plasminogen Activator

Identifiers

PMID39924100
PMCPMC12076211

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.